NanoVibronix (NAOV) Ownership - Who owns NanoVibronix?

Profile

Industry
Medical Specialties
Address
525 Executive Boulevard
Phone
+1 914 233-3004
Employees
14
Web
https://www.nanovibronix.com

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
1.8M
P/E Ratio
N/A
Total Cash
3.79M
Projected Growth
N/A
Total Debt
19K
Revenue
1M
Risk (Beta)
2.47
Dividend Yield
N/A
Total Cash/Share
1.85
Total Debt/Equity
N/A
Revenue/Share
0.62 USD as % of share price

Fundamentals

NAOV
Capitalization
1.8M
P/E Ratio
N/A
Risk (Beta)
2.47
Dividend Yield
N/A
Total Cash
3.79M
Total Cash/Share
1.85
Total Debt
19K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.62%
Revenue
1M
ROE
N/A
Book Value
4.69M
P/B Ratio
0.38
Cash Flow
N/A
Earnings
-3.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
3.00
Current Revenue Per Employee
32714.28
Dividends Per Share - Security
N/A
EBITDA
-4.49M
Float
N/A
Float - Current
N/A
Gross Income Margin
76.20
Revenue To Assets
-78.86
Shares Held By Institutions
150K
Shares Outstanding - Current
2.05M
Total Liabilities
2.67M
Total Volume MTD
N/A
Value
1
Gain YTD
-32.261
View a ticker or compare two or three
NAOV
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of noninvasive biological response-activating devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
525 Executive Boulevard
Phone
+1 914 233-3004
Employees
14
Web
https://www.nanovibronix.com